Effect of Conventional vs Intensive Management on Gestational Diabetes and Maternal Fetal Outcomes

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-45
SponsorKhyber Medical University Peshawar

About this trial

This study involved two management protocols to manage diabetes in pregnancy. Sixty patients having GDM will be recruited on the basis of the OGTT and randomly allocated to two management groups. One group of patients will receive counselling and the conventional method of management. while the other group will receive a tailored diet plan and physical activity with low caloric and moderate intense exercises. Both groups will receive a dietary plan based on their sugar levels weekly basis and physical activity with pharmacotherapy to adjust their sugar levels, while the intensive group will have rigorous monitoring on a monthly basis and frequent visits with repeated lab checks. This will help us to reduce short and long-term complications with improved maternal and neonatal outcomes.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Maternal age between 18-45 years

Gestational age at enrollment 24 - 28 weeks

Patients having Hba1c levels less then 6%

Disqualifiers

Patients having twin pregnancies

Patients having PCOS

Diabetes diagnosed prior to pregnancy

Patients having severe hypertension

Trial design

Design model

Parallel

Treatments tested in this trial

  • Dietary intervention + Physical Activity + Monitoring

    Combination product

    Dietary modifications will follow an 1800-kilocalorie structured plan that includes breakfast, two snacks, lunch, and dinner. The plan will focus on low carbohydrate intake with restrictions on lean options. Adherence will be closely monitored, with a monthly adherence questionnaire (PDAQ) to ensure tight blood sugar control. In terms of physical activity, a structured exercise plan will incorporate household activities, occupational tasks, and various levels of exercise, ranging from light to moderate and intense. Strict monitoring and follow-up will be conducted monthly using the Physical Activity Adherence Questionnaire (PAAQ). Secondly, short acting and long acting insulin dose and frquency will be monitored.

  • Usual care

    Other intervention

    General advice and recommendations for a low glycemic diet include a flexible and adjusted daily calorie intake, structured meals without a fixed menu. Patients should be educated about healthy choices and empowered to manage their own health. Exercise recommendations should be tailored to the participant's activity level, with routine ANC counseling and no standard follow-up process. If lifestyle modifications are ineffective in controlling glycemic levels, glucophage and human insulin R will be prescribed.

Treatment groups

60 Participants
are divided into 2 treatment groups
Group A: Conventional Management GroupActive comparator 1 intervention
Group B: Intensive Management GroupExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Change in HbA1c Levels

HbA1c is measured using high-performance liquid chromatography (HPLC). Values will be compared from baseline to delivery/late pregnancy and postpartum to assess improvement or deterioration in glycemic control.

Time frame
Baseline (24-28 weeks), Late Pregnancy/Delivery (37-38 weeks), Postpartum (42-45 weeks)
2

Physical Activity Level (PAQ)

Physical activity is assessed using the Physical Activity Questionnaire (PAQ), an ordinal scale ranging from 1 to 5. A score ≤2 indicates sedentary activity, while a score ≥3 indicates active physical activity levels. Higher scores reflect greater physical activity engagement.

Time frame
Conventional Management: Baseline, Delivery (37-38 weeks), Postpartum (42-45 weeks) Intensive Management: Baseline, 2nd Visit (32-34 weeks), 3rd Visit (36-38 weeks), 4th Visit (40-42 weeks), Postpartum (42-45 weeks)

Secondary outcomes

1

Fasting or Random Blood Glucose Levels

Blood glucose is measured using the enzymatic glucose oxidase method. A fasting value ≥92 mg/dL is considered abnormal, and a random value ≥200 mg/dL suggests hyperglycemia.

Time frame
Baseline; Delivery; 6-12 weeks postpartum
2

Serum Insulin Levels

Insulin is measured using chemiluminescent immunoassay. A fasting insulin level \>25 μIU/mL indicates hyperinsulinemia.

Time frame
Conventional Care Group: Baseline, Delivery. Intensive Care Group: Baseline, 32-34 weeks gestation, 36-38 weeks gestation, 40-42 weeks gestation, 6-12 weeks postpartum.
3

Serum CMPF

Serum CMPF quantified using ELISA or mass spectrometry. Reported as a continuous variable; higher values indicate increased furan fatty acid levels.

Time frame
Conventional Care Group: Baseline, Delivery. Intensive Care Group: Baseline, 32-34 weeks gestation, 36-38 weeks gestation, 40-42 weeks gestation, 6-12 weeks postpartum.
4

Total Cholesterol

Total cholesterol measured using enzymatic colorimetric assay; interpreted according to pregnancy-adjusted reference ranges.

Time frame
Conventional Care Group: Baseline, Delivery. Intensive Care Group: Baseline, 32-34 weeks gestation, 36-38 weeks gestation, 40-42 weeks gestation, 6-12 weeks postpartum.

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Khyber Medical University Peshawar

Lead sponsor

Northwest General Hospital and Research centre

Collaborator

Hayatabad Medical Complex

Collaborator